Press release
Global Periodontal Therapeutics Market to Witness Strong Growth at a CAGR of 8.7% by 2024
According to the latest forecast study, untreated periodontal disease results in chronic inflammation that leads to increased insulin resistance, reduced glucose tolerance and an increased risk of diabetic complications. To overcome this issue, many research and therapeutic development are in process for the treatment of periodontal disease. Considering this fact, a study titled “Periodontal Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016-2024” have been freshly broadcasted to the vast repository of Market Research Hub (MRH). The report on global periodontal therapeutics market, analyzes the current and future prospects of the market, with a prime focus on major regions including North America, Europe, Asia-Pacific and Rest of the World.Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1166455
Periodontal disease is a chronic bacterial infection of the periodontium affecting the tissues surrounding and supporting the teeth. In the initial section, the report consists of an executive summary that provides information about the products, its segments and sub-segments, along with a market snapshot and comparative analysis by geography, in terms of revenue % for the year 2016. A detailed overview of market dynamics, including the drivers, restraints and prospects of the periodontal therapeutics market, along with porter’s analysis, and value chain analysis of the global market, has been offered in the study. As per the research findings, the global periodontal disease therapeutics market will exhibit a CAGR of 8.7% from 2016 to 2024, rising to an estimated value of US$537.2 mn by 2024.
The research study finds that to treat bacterial infection diseases as an infectious disease, numerous therapeutic strategies aimed at eradication of periodontal pathogens have been studied over the years, including local and systemic delivery of antimicrobial and antibiotic agents. Periodontal therapeutics are the non-surgical treatment for treatment of periodontal diseases. As per the report, the factors such as rise in incidence of periodontal disease across the world, rising diabetes patient pool, increasing new product innovation and research and development activities will fuel the global periodontal therapeutics market. Some other factors such as product patient expiry, growing awareness about oral health, increasing use of tobacco will also drive the global periodontal therapeutics market over the report’s forecast period.
Make An Enquiry: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1166455
Moreover, the research study segments the market by product, distribution channel and regions. In terms of periodontal therapeutics products, the global market has been segmented into systemic antibiotics and local antibiotics. Among these, the segment of systemic antibiotics held a clear dominance in 2016. Factors such as product affordability, availability, and high market penetration will continue to drive the demand for systemic antibiotics for the treatment of periodontal diseases. The report also analyzes that the segment is predicted to continue to remain at top in terms of revenue. Apart from that, the segment of local antibiotics is expected to lead in terms of growth rate. On the basis of end users, the market is segmented as hospitals pharmacies, retail pharmacies, drug stores and E-Commerce.
Browse Full Report With TOC: http://www.marketresearchhub.com/report/periodontal-therapeutics-market-global-industry-analysis-size-share-growth-trends-and-forecast-2016-2024-report.html
The study further presents competitive landscape of the market by profiling key market players, such as 3M, Valeant Pharmaceuticals International, Inc., Den-Mat Holdings, LLC Dexcel Pharma, Galderma S.A. among others
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: marketresearchhub.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Periodontal Therapeutics Market to Witness Strong Growth at a CAGR of 8.7% by 2024 here
News-ID: 613750 • Views: …
More Releases from Medical Industry Research Reports - MRH

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Report includes an overview of trial numbers and their average enrollment…

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Reviewed, …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and…

Chronic Liver Disease Global Clinical Trials Reviewed H1 – 2017: Pharmaceutica …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Liver Disease Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Liver Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Liver Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the…

Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review H1 – 2017: Ma …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…